-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.63-29.44% Downside
Aadi Bioscience, Inc. Frequently Asked Questions
-
What analysts cover Aadi Bioscience, Inc.?
Aadi Bioscience, Inc. has been rated by research analysts at Piper Sandler, Jefferies in the past 90 days.